Cyclic AMP, a mediator of GLP-1, acts in concert with glucose and tolbutamide to increase cytosolic Ca2+ in pancreatic B-cells.
Yaekura
K
K
Department of Physiology, Kagoshima University School of Medicine, Japan.
Nakata
M
M
Tanaka
H
H
Yada
T
T
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism*; D002478:Cells, Cultured; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D003600:Cytosol / Q000378:metabolism; D005934:Glucagon; D052216:Glucagon-Like Peptide 1; D004763:Glucagon-Like Peptides; D005947:Glucose / Q000494:pharmacology*; D007515:Islets of Langerhans / Q000187:drug effects / Q000502:physiology*; D010446:Peptide Fragments / Q000494:pharmacology*; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D014044:Tolbutamide / Q000494:pharmacology*
D010446:Peptide Fragments; C055453:glucagon-like peptide 1 (7-36)amide; D005576:Colforsin; D004763:Glucagon-Like Peptides; D003994:Bucladesine; D011189:Potassium Chloride; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D014044:Tolbutamide; D000242:Cyclic AMP; D005947:Glucose; D002118:Calcium; D015056:1-Methyl-3-isobutylxanthine